Research Overview
What palmitoylation changes
Relationship to AHK-Cu
Both molecules use the Ala-His-Lys core, but AHK-Cu is a copper(II) coordination complex and Pal-AHK is a lipidated copper-free peptide. Copper binding in the short His-containing tripeptides depends on the amino-terminal nitrogen together with the imidazole side chain, so a correctly N-palmitoylated peptide is not expected to chelate copper in the same geometry, and the two materials differ in mass, charge, colour and solubility. A study comparing them should control peptide molarity, copper concentration and vehicle separately. Similar names do not imply equal solubility, target engagement or biological response.
Research questions
- Dermal-papilla cell viability, proliferation and apoptosis markers
- Follicle-organ culture and extracellular-matrix expression endpoints
- Partitioning between water, oil and interfacial phases in model formulations
- Aggregation state and apparent solubility limit in the actual assay buffer
- Franz-cell or membrane-permeation comparison with unmodified AHK
- Single-agent comparisons with AHK-Cu, GHK-Cu and Pal-GHK
Analytical and vehicle controls
Ala-His-Lys carries no strong chromophore beyond the histidine imidazole, so ultraviolet detection is weak and quantification generally leans on low-wavelength absorbance, evaporative or charged-aerosol detection, or mass spectrometry. The tripeptide also has two amine sites—the terminal alpha-amino group and the lysine side chain—so where the lipid sits is an identity question worth confirming rather than assuming. Co-solvents and surfactants used to keep the peptide dissolved have their own effects on cells and on barrier models, so each arm needs a vehicle-matched control at the same concentration and an established positive control to read the assay against.
Evidence limit
Much of the discussion around Pal-AHK extrapolates from non-palmitoylated AHK or copper-peptide studies. That extrapolation is a hypothesis, not a demonstrated equivalence. Use compound-specific data, matched vehicle controls and analytical confirmation that the amphiphilic peptide remains in solution during the assay. Where an observation is reported only for a formulated blend, the contribution of this single peptide is not separable without a matched blend that omits it.
